Par Form Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?
PAR FORM has three approved drugs.
There is one tentative approval on PAR FORM drugs.
Drugs and US Patents for Par Form
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Form | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 201511-001 | Feb 12, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Par Form | DICLOFENAC POTASSIUM | diclofenac potassium | FOR SOLUTION;ORAL | 202964-001 | May 2, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Form | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 201509-002 | Aug 1, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Form | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 201509-001 | Aug 1, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.